...
首页> 外文期刊>PLoS One >Uterine transplantation and IVF for congenital or acquired uterine factor infertility: A systematic review of safety and efficacy outcomes in the first 52 recipients
【24h】

Uterine transplantation and IVF for congenital or acquired uterine factor infertility: A systematic review of safety and efficacy outcomes in the first 52 recipients

机译:子宫移植和IVF用于先天性或获得的子宫因子不育症:对前52名受者的安全性和疗效结果进行了系统审查

获取原文

摘要

Uterine transplantation (UTx) associated with IVF restores fertility in women affected by absolute uterine factor infertility (AUFI). Pregnancies achieved both in women undergoing any solid organ transplantation and following IVF are associated with an increased risk of maternal and neonatal complications. This systematic review evaluated this risk in UTx-IVF treated women focusing on the safety and efficacy features of the treatment. Twenty-two studies and three press releases reporting on 52 UTx-IVF treatments were identified. Regarding the safety of treatment, 38/52 (73,1%) of surgical procedures led to the restoration of uterine function in recipients, 12/52 (23,1%) of recipients experienced post-operative complications requiring hysterectomy, and 2/52 (3,8%) of procedures failed before uterine recipients’ surgery due to intra-operative complications. Regarding the efficacy of treatment, results focused on transplanted patients showing full recovery of organ functioning: 16/38 (42,1%) of patients achieved a pregnancy, including two women who gave births twice. UTx-IVF pregnancies led to 16 deliveries and all new-borns were healthy. Six out of 16 (37,5%) UTx pregnancies faced major complications during gestation. Preterm births occurred in 10/16 (62,5%) UTx deliveries. Our data indicates that the risk of gestational and delivery complications deserves important consideration in AUFI women receiving UTx-IVF treatments. However, these observations are preliminary and need to be revised after larger series of data are published.
机译:与IVF相关的子宫移植(UTX)恢复受绝对子宫因子不孕症(AUFI)影响的妇女的生育率。经历任何固体器官移植和IVF后的女性患有妊娠的妊娠与母体和新生儿并发症的风险增加有关。这种系统审查评估了UTX-IVF治疗妇女的这种风险,重点是治疗的安全性和功效特征。确定了2002项研究和三次新闻稿关于52 UTX-IVF治疗的报告。关于治疗的安全性,38/52(73,1%)的外科手术导致受者中子宫功能的恢复,12/52(23,1%)受者经历了需要子宫切除术的术后并发症,2 / 52(3,8%)程序在子宫受体因手术内并发症引起的手术前失败。关于治疗的疗效,重点关注移植的患者,显示有机器官功能的全部恢复:16/38(42,1%)患者患者患有怀孕,其中两名妇女患有两次孕育。 UTX-IVF怀孕导致16个交付,所有新生儿都是健康的。 16名(37,5%)UTX怀孕中的六个妊娠在妊娠期间面临着重症并发症。早产出生在10/16(62,5%)UTX交付中发生。我们的数据表明,妊娠和交付并发症的风险值得在AUFI妇女接受UTX-IVF治疗的重要考虑。但是,这些观察结果是初步的,并且在发布大量数据后需要修改。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号